Particulars |
Company Name |
Glenmark Life Sciences Ltd |
Year End |
202403 |
Full Year |
Equity (Rs Cr.) |
24.51 |
B.V. Rs |
207.20 |
Sales Rs Cr. |
2,283.21 |
NP Rs Cr. |
471.41 |
NP Var% |
1.00 |
Div% |
1,125.00 |
CPS Rs |
42.80 |
EPS Rs |
38.50 |
Traded Value(Rs Lakhs) |
79.37 |
52 Week High |
1,335.00 |
52 Week Low |
609.00 |
Price BSE |
1,015.00 |
Price NSE |
1,017.00 |
Market Capital(Rs Cr.) |
12,439.72 |
P/C Ratio |
23.70 |
P/E Ratio |
26.40 |
Price Vs.BV |
4.90 |
|
Latest Quarter |
Year End |
202409 |
Sales Rs Cr. |
506.88 |
NP Rs Cr. |
95.32 |
NP Var % |
-20.00 |
Trailing Twelve Months |
Year End |
202409 |
Sales |
2,035.73 |
OPM |
28.43 |
NP |
418.22 |
NP Var% |
-16.23 |
EPS |
34.56 |
PE |
29.38 |
|
|